Improving efficiency of ALS clinical trials: a sponsor's perspective.
Markabi
S
S
Novartis Pharma AG, 4002 Basel, Switzerland.
Schadrack
J
J
D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy*; D015415:Biomarkers; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D006801:Humans; D012107:Research Design
D015415:Biomarkers